Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cerebrovascular circulation is the complex system of arteries and veins responsible for supplying the brain with oxygenated blood and nutrients while removing metabolic waste products (StatPearls, 2023). It is characterized by unique physiological features, such as the Circle of Willis, which provides collateral circulation to safeguard against arterial blockages, and the Blood-Brain Barrier, which strictly regulates the passage of substances from the blood into the neural parenchyma (NIH/NINDS, 2023). The system employs robust autoregulatory mechanisms that ensure constant cerebral blood flow despite fluctuations in systemic blood pressure (PubMed, 2021). Dysfunction of the cerebrovascular circulation is a primary driver of neurological morbidity and mortality, manifesting in conditions such as ischemic stroke, intracranial hemorrhage, and vascular dementia (AHA/ASA, 2021). Pharmacological interventions do not target the circulation as a single molecule but rather address specific components like vascular smooth muscle, coagulation factors, or osmotic balance to restore perfusion and protect neural tissue (StatPearls, 2023). As it is a physiological process rather than a discrete protein, receptor, or enzyme, it is classified here as an incorrect molecular target in the context of specific drug-receptor binding models.
Drugs targeting this system generally act by modulating vascular smooth muscle tone to induce vasodilation (e.g., calcium channel blockers), dissolving intravascular thrombi (thrombolytics), inhibiting platelet aggregation (antiplatelets), or reducing intracranial pressure through osmotic gradients (osmotic diuretics).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cerebrovascular circulation.